https://www.selleckchem.com/pr....oducts/sirpiglenasta
ted data sets are expected to be complete in September 2020. The SAFEBOD study will overcome current limitations in organ donation by accessing comprehensive information on referred organ donors and recipients in existing data sets. The study will provide robust estimates of disease transmission and nontransmission events based on recent data. It will also describe the agreement between perceived risk estimated at the time of referral and verified risk when all health outcome data are accessible. The improved understanding of tra
Gefällt mir
Kommentar
Teilen
